230 related articles for article (PubMed ID: 29109448)
21. Absorption-Enhancing Mechanisms of Capryol 90, a Novel Absorption Enhancer, for Improving the Intestinal Absorption of Poorly Absorbed Drugs: Contributions to Trans- or Para-Cellular Pathways.
Ukai H; Imanishi A; Kaneda A; Kimura E; Koyama M; Morishita M; Katsumi H; Yamamoto A
Pharm Res; 2020 Nov; 37(12):248. PubMed ID: 33230672
[TBL] [Abstract][Full Text] [Related]
22. Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.
Hashimoto Y; Tachibana K; Krug SM; Kunisawa J; Fromm M; Kondoh M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426497
[TBL] [Abstract][Full Text] [Related]
23. Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression.
Miyoshi Y; Tanabe S; Suzuki T
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G105-16. PubMed ID: 27151944
[TBL] [Abstract][Full Text] [Related]
24. [Non-invasive drug delivery system with the claudin binder].
Takahashi A; Kondoh M; Yagi K
Yakugaku Zasshi; 2011; 131(11):1583-7. PubMed ID: 22041696
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.
Iraha A; Chinen H; Hokama A; Yonashiro T; Kinjo T; Kishimoto K; Nakamoto M; Hirata T; Kinjo N; Higa F; Tateyama M; Kinjo F; Fujita J
World J Gastroenterol; 2013 Sep; 19(33):5500-7. PubMed ID: 24023493
[TBL] [Abstract][Full Text] [Related]
26. Bioactive factors secreted by Bifidobacterium breve B-3 enhance barrier function in human intestinal Caco-2 cells.
Kurose Y; Minami J; Sen A; Iwabuchi N; Abe F; Xiao J; Suzuki T
Benef Microbes; 2019 Feb; 10(1):89-100. PubMed ID: 30353739
[TBL] [Abstract][Full Text] [Related]
27. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
[TBL] [Abstract][Full Text] [Related]
28. Cholera toxin perturbs the paracellular barrier in the small intestinal epithelium of rats by affecting claudin-2 and tricellulin.
Markov AG; Vishnevskaya ON; Okorokova LS; Fedorova AA; Kruglova NM; Rybalchenko OV; Aschenbach JR; Amasheh S
Pflugers Arch; 2019 Sep; 471(9):1183-1189. PubMed ID: 31222489
[TBL] [Abstract][Full Text] [Related]
29. Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model.
Nakajima M; Nagase S; Iida M; Takeda S; Yamashita M; Watari A; Shirasago Y; Fukasawa M; Takeda H; Sawasaki T; Yagi K; Kondoh M
J Pharmacol Exp Ther; 2015 Sep; 354(3):440-7. PubMed ID: 26139628
[TBL] [Abstract][Full Text] [Related]
30. Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
Mitchell LA; Koval M
Toxins (Basel); 2010 Jul; 2(7):1595-611. PubMed ID: 22069652
[TBL] [Abstract][Full Text] [Related]
31. Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells.
Kojima T; Kondoh M; Keira T; Takano KI; Kakuki T; Kaneko Y; Miyata R; Nomura K; Obata K; Kohno T; Konno T; Sawada N; Himi T
Drug Deliv; 2016 Oct; 23(8):2703-2710. PubMed ID: 26036653
[TBL] [Abstract][Full Text] [Related]
32. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways.
Beutheu Youmba S; Belmonte L; Galas L; Boukhettala N; Bôle-Feysot C; Déchelotte P; Coëffier M
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):463-70. PubMed ID: 22197938
[TBL] [Abstract][Full Text] [Related]
34. Sec61β regulates barrier functions of tight junction through expression of claudin-4 in Madin-Darby canine kidney cells.
Washiyama M; Koizumi N; Fujii M; Watanabe Y
Biol Pharm Bull; 2014; 37(6):979-86. PubMed ID: 24882410
[TBL] [Abstract][Full Text] [Related]
35. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.
Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA
J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
[TBL] [Abstract][Full Text] [Related]
37. Tight junctions. Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin.
Saitoh Y; Suzuki H; Tani K; Nishikawa K; Irie K; Ogura Y; Tamura A; Tsukita S; Fujiyoshi Y
Science; 2015 Feb; 347(6223):775-8. PubMed ID: 25678664
[TBL] [Abstract][Full Text] [Related]
38. Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury.
Wray C; Mao Y; Pan J; Chandrasena A; Piasta F; Frank JA
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L219-27. PubMed ID: 19447895
[TBL] [Abstract][Full Text] [Related]
39. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
Li X; Saeki R; Watari A; Yagi K; Kondoh M
Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
[TBL] [Abstract][Full Text] [Related]
40. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P
Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
